Publikasjoner
NIBIOs ansatte publiserer flere hundre vitenskapelige artikler og forskningsrapporter hvert år. Her finner du referanser og lenker til publikasjoner og andre forsknings- og formidlingsaktiviteter. Samlingen oppdateres løpende med både nytt og historisk materiale. For mer informasjon om NIBIOs publikasjoner, besøk NIBIOs bibliotek.
2025
Sammendrag
Det er ikke registrert sammendrag
Forfattere
Daniel Flø Johan A. Stenberg Lawrence Richard Kirkendall Kjetil Klaveness Melby Anders Nielsen Selamawit Tekle Gobena Beatrix Alsanius Jorunn Børve Paal Krokene Christer Magnusson Mogens Nicolaisen Line Nybakken May-Guri Sæthre Iben Margrete ThomsenSammendrag
VKM has assessed the environmental and health risks associated with the use of the mites Acarus siro and Suidasia pontifica as feed for various predatory insects and mites. Background POWERFOOD 3.0 is used as feed for various predatory mites and predatory insects. Acarus siro, Suidasia pontifica, and Carpoglyphus lactis constitute the product. Carpoglyphus lactis has previously been assessed by VKM. VKM has now prepared an environmental and health risk assessment of A. siro and S. pontifica. Conclusions Acarus siro occurs naturally in Norway, and new introductions will most likely be able to establish and spread in Norway. Suidasia pontifica, on the other hand, has never been recorded in the wild in Norway, and its tropical origin suggests that it will not establish and spread in Norway. No records of negative effects of A. siro and S. pontifica on biodiversity were found. Several studies report allergies to mites, including the species in the product POWERFOOD 3.0. The likelihood of developing mite allergies after handling the product is therefore high. However, the likelihood of allergic reactions following consumption of plants treated with the product appears to be low. Regarding taxonomic challenges that may affect the risk assessment, VKM found out that A. siro can be mistaken for A. farris and A. immobilis. These species differ only slightly in development and ecology. From the limited available knowledge about their biology, these three species are expected to have similar effects on biodiversity and human health. There are no known problems with species identification for Suidasia pontifica. The taxonomic issue with this species is that much of the literature uses an invalid name; S. medanensis. The risk assessment is approved by VKM's Panel on Plant Health.
Forfattere
Daniel Flø Johan A. Stenberg Lawrence Richard Kirkendall Kjetil Klaveness Melby Anders Nielsen Selamawit Tekle Gobena Beatrix Alsanius Jorunn Børve Paal Krokene Christer Magnusson Mogens Nicolaisen Line Nybakken May-Guri Sæthre Iben M. Thomsen Sandra WrightSammendrag
VKM has assessed the environmental and health risks associated with the use of the mite Lepidoglyphus destructor as feed. Background Anso-Mite Plus consists of the biological control agent Amblyseius andersoni and the feed organisms Carpoglyphus lactis and Lepidoglyphus destructor. Amblyseius andersoni and C. lactis have previously been assessed by VKM. VKM has now assessed the environmental and health risks of L. destructor. Conclusions Lepidoglyphus destructor has been found in homes, agricultural environments, and stored products in Norway. The species is well established in Norway, and introduced individuals are expected to be able to establish and spread. Lepidoglyphus destructor is widespread and common in Norway, and it seems unlikely that further introductions via Anso-Mite Plus will have any additional effects on biodiversity. Several studies report allergies to mites, including to L. destructor. The likelihood of developing mite allergies after handling the product is therefore high. However, the likelihood of allergic reactions after consuming plants treated with the product appears to be low. Lepidoglyphus is not a species-rich genus, and there is no documentation suggesting that L. destructor can be confused with other species. The risk assessment is approved by VKM's Panel on Plant Health.
Forfattere
Daniel Flø Johan A. Stenberg Kjetil Klaveness Melby Selamawit Tekle Gobena Beatrix Alsanius Jorunn Børve Paal Krokene Christer Magnusson Mogens Nicolaisen Line Nybakken May-Guri Sæthre Iben M. Thomsen Sandra WrightSammendrag
VKM has assessed possible health hazards associated with the use of frozen eggs of Sitotroga cerealella as feed. Background The plant protection products CHRYSObio and CHRYSOcontrol contain Chrysoperla carnea and frozen eggs of Sitotroga cerealella. The eggs are used as feed for the larvae of C. carnea, the beneficial organism in the products. VKM has previously assessed environmental and health risks associated with C. carnea. Since the eggs of S. cerealella are frozen (dead), VKM has now assessed only human health hazard associated with the eggs in the products CHRYSObio and CHRYSOcontrol. Conclusion Insect eggs, frozen or not, can carry pathogens that may be harmful to humans. Freezing can kill some of these pathogens, but some hardy pathogens can survive low temperatures. Some people are allergic to insect proteins, and freezing does not eliminate such proteins. However, VKM found no reports identifying eggs of S. cerealella neither as carriers of pathogens nor as a cause of allergies in humans. The risk assessment is approved by VKM's Panel on Plant Health.
Forfattere
Monica Sanden Eirill Ager-Wick Johanna Eva Bodin Nur Duale Anne-Marthe Ganes Jevnaker Kristian Prydz Volha Shapaval Ville Erling Sipinen Tage ThorstensenSammendrag
The Norwegian Scientific Committee for Food and Environment (VKM) has assessed an application for approval of the genetically modified maize DAS1131 for food and feed uses, import and processing in the EU. In accordance with an assignment specified by the Norwegian Food Safety Authority (NFSA) and the Norwegian Environment Agency (NEA), VKM assesses whether genetically modified organisms (GMOs) intended for the European market can pose risks to human or animal health, or the environment in Norway. VKM assesses the scientific documentation regarding GMO applications seeking approval for use of GMOs as food and feed, processing, or cultivation. The EU Regulation 1829/2003/EC (Regulation) covers living GMOs that fall under the Norwegian Gene Technology Act, as well as processed food and feed from GMOs (dead material) that fall under the Norwegian Food Act. The regulation is currently not part of the EEA agreement or implemented in Norwegian law. Norway conducts its own assessments of GMO applications in preparation for the possible implementation of the Regulation. In accordance with the assignment by NFSA and NEA, VKM assesses GMO applications during scientific hearings initiated by the European Food Safety Authority (EFSA), as well as after EFSA has published its own risk assessment of a GMO, up until EU member countries vote for or against approval in the EU Commission. The assignment is divided into three stages. (link) Genetically modified maize DAS1131 DAS1131 is a genetically modified maize developed by Agrobacterium tumefaciens -mediated transformation. Maize DAS1131 plants contain the transgenes cry1Da2 and dgt-28 epsps which encode the protein Cry1Da2 and the enzyme DGT-28 EPSPS, respectively. Cry1Da2 provides resistance to certain susceptible Lepidopteran (order of butterflies and moths) pests and the enzyme DGT-28 EPSPS provides tolerance to glyphosate-based herbicides. VKM has assessed the documentation in application GMFF-2021-1530 and EFSA's scientific opinion on genetically modified maize DAS1131. VKM concludes that the applicant's scientific documentation for the genetically modified maize DAS1131 is satisfactory for risk assessment, and in accordance with EFSA guidelines for risk assessment of genetically modified plants for food or feed uses. The genetic modifications in maize DAS1131do not indicate an increased health or environmental risk in Norway compared with EU countries. EFSA's risk assessment is therefore sufficient also for Norwegian conditions. As no specific Norwegian conditions have been identified regarding properties of the genetically modified maize DAS1131, VKM's GMO panel has not performed a complete risk assessment of the maize. About the assignment: In stage 1, VKM shall assess the health and environmental risks of the genetically modified organism and derived products in connection with the EFSA scientific hearing of GMO applications. VKM shall review the scientific documentation that the applicant has submitted and possibly provide comments to EFSA. VKM must also consider: i) whether there are specific Norwegian conditions that could give other risks in Norway than those mentioned in the application, ii) whether the Norwegian diet presents a different health risk for the Norwegian population should the GMO be approved, compared to the European population, and iii) risks associated with co-existence with conventional and/or ecologic production of plants for GMOs seeking approval for cultivation. Relevant measures to ensure co-existence must also be considered. In stage 2, VKM shall assess whether comments from Norway have been satisfactorily answered by EFSA. In addition, VKM shall assess whether comments from other countries imply need for further follow-up. (...)
Sammendrag
Det er ikke registrert sammendrag
Sammendrag
Det er ikke registrert sammendrag
Sammendrag
Det er ikke registrert sammendrag
Sammendrag
Det er ikke registrert sammendrag
Sammendrag
Det er ikke registrert sammendrag